Investors > News Releases
Oct 22, 2018
Myriad’s BRACAnalysis CDx® Test Identifies Patients with Newly Diagnosed Advanced Ovarian Cancer Who May Benefit from Maintenance Treatment with Lynparza®
Products
Oct 19, 2018
New Studies Highlight Performance of Vectra® Test in Patients with Rheumatoid Arthritis Who Were Treated with Tofacitinib and Rituximab
Pipeline
Oct 18, 2018
Bendcare Endorses Vectra® Testing for Patients with Rheumatoid Arthritis
Products
Oct 16, 2018
Myriad Receives FDA Approval of BRACAnalysis CDx® as Companion Diagnostic for Pfizer’s TALZENNA® (talazoparib)
Products
Oct 10, 2018
Myriad Announces New Laboratory Agreement with Pfizer®
Products
Oct 09, 2018
Myriad and Pfizer Build Upon a Previously Announced Companion Diagnostic Agreement
Products
Oct 03, 2018
Myriad Genetics Announces Four Presentations at the 2018 American College of Rheumatology Annual Meeting
Products
Sep 26, 2018
Myriad Announces New GeneSight® Study Published in Personalized Medicine
Products
Sep 25, 2018
Myriad Announces Publication of Variant Reclassification Study in the Journal of the American Medical Association
Corporate
Aug 31, 2018
Myriad Genetics to Present at the 2018 Morgan Stanley Global Healthcare Conference
Corporate
Aug 21, 2018
Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results
Financial
Aug 13, 2018
Myriad Reschedules Release of Fiscal Fourth-Quarter 2018 Financial Results
Corporate
Aug 01, 2018
Myriad to Announce Fiscal Fourth-Quarter 2018 Financial Results on August 14, 2018
Financial
Jul 31, 2018
Myriad Announces Closing of Counsyl Acquisition
Corporate
Jul 25, 2018
Myriad Announces Publication of IMPACT Study in Journal of Psychiatric Research
Products